Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions, retirements and layoffs occurring across the healthcare industry.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.